Literature DB >> 28754431

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis.

Alexandre Wagner Silva de Souza1, Ana Luisa Calich2, Henrique de Ataíde Mariz3, Manuella Lima Gomes Ochtrop4, Ana Beatriz Santos Bacchiega4, Gilda Aparecida Ferreira5, Jozelia Rêgo6, Mariana Ortega Perez7, Rosa Maria Rodrigues Pereira7, Wanderley Marques Bernardo8, Roger Abramino Levy4.   

Abstract

The purpose of these recommendations is to guide the appropriate induction treatment of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) patients with active disease. The recommendations proposed by the Vasculopathies Committee of the Brazilian Society Rheumatology for induction therapy of AAV, including granulomatosis with polyangiitis, microscopic polyangiitis and renal-limited vasculitis, were based on systematic literature review and expert opinion. Literature review was performed using Medline (PubMed), EMBASE and Cochrane database to retrieve articles until October 2016. PRISMA guidelines were used for the systematic review and articles were assessed according to the Oxford levels of evidence. Sixteen recommendations were made regarding different aspects of induction therapy for AAV. The purpose of these recommendations is to serve as a guide for therapeutic decisions by health care professionals in the management of AAV patients presenting active disease.
Copyright © 2017. Published by Elsevier Editora Ltda.

Entities:  

Keywords:  ANCA-associated vasculitis; Diretrizes; Granulomatose com poliangiite; Granulomatosis with polyangiitis; Guidelines; Microscopic polyangiitis; Poliangiite microscópica; Renal-limited vasculitis; Vasculite associada a ANCA; Vasculite limitada ao rim

Mesh:

Year:  2017        PMID: 28754431     DOI: 10.1016/j.rbre.2017.06.003

Source DB:  PubMed          Journal:  Rev Bras Reumatol Engl Ed        ISSN: 2255-5021


  5 in total

1.  An update on the general management approach to common vasculitides.

Authors:  Mooikhin Hng; Sizheng S Zhao; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

Review 2.  Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Duvuru Geetha; Qiuyu Jin; Jennifer Scott; Zdenka Hruskova; Mohamad Hanouneh; Mark A Little; Vladimir Tesar; Philip Seo; David Jayne; Christian Pagnoux
Journal:  Kidney Int Rep       Date:  2018-05-24

3.  Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes.

Authors:  Chunjia Li; Yu Zou; Xin Lu; Guochun Wang; Xiaoming Shu
Journal:  Ther Adv Chronic Dis       Date:  2020-06-09       Impact factor: 5.091

4.  The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis.

Authors:  Anji Xiong; Chen Xiong; Guancui Yang; Yu Shuai; Deng Liu; Linqian He; Zepeng Guo; Liangwen Zhang; Yi Liu; Yuan Yang; Beibei Cui; Shiquan Shuai
Journal:  Front Med (Lausanne)       Date:  2021-03-01

5.  Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors:  Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.